NCL Research & Financial Services Limited has scheduled a meeting of its Board of Directors for August 21, 2026, to advance plans for a proposed rights issue. The meeting follows an earlier board discussion held on February 23, 2026, which initiated the process.

The primary objective of the upcoming meeting is to approve various critical parameters governing the capital raise. The board will determine the specific issue price and the total size of the rights issue. Additionally, directors will fix the exchange ratio, also referred to as the rights entitlement ratio, which defines how many new shares existing shareholders can subscribe to.

Key Agenda Items

The board is set to address several logistical and regulatory components essential for launching the offer. Key decisions include:

• Fixing the record date to ascertain eligible shareholders.
• Determining the issue opening and closing dates.
• Setting the last date for market renunciation of rights.
• Adopting the Letter of Offer (LOF), Abridged Letter of Offer (ALOF), Rights Entitlement Letter (REL), and Composite Application Form (CAF).

Goutam Bose, Managing Director of NCL Research & Financial Services, signed the notice dated August 17, 2026. The company communicated these details to BSE Limited, requesting that the information be taken on record.

What the Numbers Show

The source document provides procedural details regarding the corporate action but does not disclose financial figures such as the target raise amount, current market capitalization, or existing debt levels. Consequently, no financial impact analysis can be derived from this filing alone. The focus remains strictly on the regulatory and structural setup of the rights issue.

NCL Research & Financial Services received in-principle approval from the Bombay Stock Exchange (BSE) for its proposed rights issue of fully paid-up equity shares. The exchange granted the permission on August 14, 2026, allowing the company to use the exchange’s name in its Letter of Offer, provided it includes the mandatory disclaimer clauses.

The approval follows the company’s application dated February 24, 2026. The BSE clarified that this permission is for limited internal purposes regarding listing eligibility and does not warrant the correctness of the offer document or the financial soundness of the company. Investors are advised to conduct independent inquiry before subscribing.

Key Compliance Requirements

The company must adhere to several statutory and regulatory conditions before finalizing the offer documents. Key requirements include:

• Fixing a record date with at least three working days’ advance notice to the exchange.
• Disclosing the rights issue price at least three working days prior to the record date.
• Ensuring dematerialization agreements are in place with all depositories.
• Obtaining Designated Stock Exchange approval for the Basis of Allotment, even in cases of under-subscription.
• Appointing a qualified Company Secretary as the Compliance Officer under Regulation 6(1) of SEBI (LODR) Regulations, 2015.
• Procuring an ODI compliance certificate from a Secretarial Auditor before filing the listing application.

The company remains solely responsible for disclosures in the offer document and any consequences arising from non-disclosure or misstatement. Dealings in Letters of Renunciation will be permitted only after the posting of the letter of offer and composite application form is completed.